$1.38
2.13%
Nasdaq, Sep 02, 06:46 pm CET
ISIN
US5713541093
Symbol
MRAI
Sector
Industry

Marpai Stock price

$1.38
+0.03 2.22% 1M
+0.43 45.26% 6M
+0.43 45.26% YTD
+0.83 150.91% 1Y
-2.22 61.67% 3Y
-14.62 91.38% 5Y
-14.62 91.38% 10Y
-14.62 91.38% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
-0.03 2.13%
ISIN
US5713541093
Symbol
MRAI
Sector
Industry

Key metrics

Basic
Market capitalization
$23.8m
Enterprise Value
$34.2m
Net debt
$10.4m
Cash
$730.0k
Shares outstanding
14.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.9 | 0.3
EV/Sales
1.3 | 0.5
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-215.2%
Return on Equity
79.7%
ROCE
315.5%
ROIC
-274.0%
Debt/Equity
-0.4
Financials (TTM | estimate)
Revenue
$26.2m | $68.2m
EBITDA
$-17.7m | $4.9m
EBIT
$-19.1m | $-3.8m
Net Income
$-20.8m | $-5.8m
Free Cash Flow
$-11.7m
Growth (TTM | estimate)
Revenue
-24.8% | 142.0%
EBITDA
10.0% | 142.8%
EBIT
18.6% | 72.4%
Net Income
14.1% | 73.8%
Free Cash Flow
8.6%
Margin (TTM | estimate)
Gross
32.5%
EBITDA
-67.7% | 7.2%
EBIT
-73.1%
Net
-79.4% | -8.5%
Free Cash Flow
-44.6%
More
EPS
$-1.4
FCF per Share
$-0.8
Short interest
0.2%
Employees
117
Rev per Employee
$240.0k
Show more

Is Marpai a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Marpai Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Marpai forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Marpai forecast:

Buy
86%
Hold
14%

Financial data from Marpai

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
26 26
25% 25%
100%
- Direct Costs 18 18
22% 22%
67%
8.53 8.53
30% 30%
33%
- Selling and Administrative Expenses 19 19
35% 35%
73%
- Research and Development Expense 0.03 0.03
96% 96%
0%
-18 -18
10% 10%
-68%
- Depreciation and Amortization 1.41 1.41
63% 63%
5%
EBIT (Operating Income) EBIT -19 -19
19% 19%
-73%
Net Profit -21 -21
14% 14%
-79%

In millions USD.

Don't miss a Thing! We will send you all news about Marpai directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Marpai Stock News

Neutral
Seeking Alpha
20 days ago
Marpai, Inc. (OTCQX:MRAI) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Damien Francis Lamendola - CEO & Director Steve Johnson - CFO & Company Secretary Operator Good morning, and welcome to the Marpai Second Quarter 2025 Earnings Webcast. [Operator Instructions] Please note, this event is being recorded.
Neutral
PRNewsWire
20 days ago
Marpai Slashes Losses by Two-Thirds in Q2 2025, Paving the Way to Profitability. Operating Expenses Cut 70% as Turnaround Gains Traction TAMPA, Fla.
Neutral
PRNewsWire
26 days ago
TAMPA, Fla. , Aug. 7, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services.
More Marpai News

Company Profile

Marpai, Inc. offers a SMART health plan services system that transforms health plan into a health empowerment tool. It provides health plan services system addresses the problems of healthcare. The firm uses deep learning, artificial intelligence, to empower people to live better, stay strong and spend less on healthcare. Its SMART health plan services enables companies to provide better healthcare to employees and significantly reduce administration, reinsurance and care costs. The company was founded in January 2021 and is headquartered in Tampa, FL.

Head office United States
CEO Damien Lamendola
Employees 117
Founded 2021
Website www.marpaihealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today